Dilip Girdharlal Shah

Fresenius Kabi Oncology Ltd. is a research and development company, which engages in manufacturing and development of oncology drugs. It also develops active pharmaceutical ingredients, intermediates and oral and injectable finished dosage forms. The company was founded on March 18, 2003 and is headquartered in Gurgaon, India.

Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. It focuses on therapeutic areas, such as the gynecology, cardiovascular, Vitamins, minerals and nutrients, Anti-invectives, gastrointestinal, blood related oncology/anti-neoplastics, HIV, neurology, respiratory and anti-diabetic therapeutic areas. The company offers a wide range of products and services under Formulations, Biologics and Active Pharmaceutical Ingredients. It produces pharmaceutical and biopharmaceutical products of a range of dosage forms, including oral solids, oral liquids, injectables including lipid, liposomal, lyophilized injectables, biologics, vaccines and complex APIs, including chiral molecules and cytotoxic products. Emcure Pharmaceuticals was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India.

Zuventus Healthcare Ltd operates as pharmaceutical company. The company was founded in 15th July, 2002 and is headquartered in Mumbai, India.

The Indian Pharmaceutical Association is an organization that focuses on the pharmaceutical industry in India. The company publishs the Indian Journal of Pharmaceutical Sciences, a bi-monthly scientific publication that features original research work in the field. The association is based in Mumbai, India and was founded by Bavaguthu Raghuram Shetty. The organization also awards fellowships to members who have made distinguished contributions to the pharmacy profession. Contact information for the organization is available on their website. Additionally, they publish a monthly newsmagazine called Pharma Times which features articles of professional interest and proceedings of the Central Executive Committee meetings.